This work will focus on the proteins involved in the replication of adenovirus DNA. Specifically, DNA encoding these proteins will be moved onto bacterial plasmids which will allow expression of the viral DNA in bacteria. The proteins of interest are the E2b terminal protein, the E2b encoded polymerase and the 72K DBP from region E2a. These proteins will be synthesized as fusion products containing less than 15 amino acids, and in some cases only 1, from the Beta-galactosidase gene of E. coli or the cro gene of lambda. The microbially synthesized products will be purified and tested in vitro for their ability to function in adenovirus replication assays. Subsequently, specific modifications will be made in the primary structure of these proteins by altering the DNA encoding them. The effect of these alterations on the activity and properties of these proteins will then be tested. Conditional lethal mutations in the adenovirus terminal protein as well as additional mutations within the 120k polymerase gene will also be created in intact virus. These mutations will be characterized for their effect on viral DNA replication and on the virus growth cycle. We will also create antisera against these proteins by utilizing synthetic peptides as well as fragments of the proteins synthesized in bacteria as antigens. These sera will be used to study the synthesis and role of the replication proteins in the infected HeLa cell.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Modified Research Career Development Award (K04)
Project #
Application #
Study Section
Virology Study Section (VR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University of New York at Buffalo
School of Medicine & Dentistry
United States
Zip Code
Clark, Mary C; Baum, Linda G (2012) T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival. Ann N Y Acad Sci 1253:58-67
Mandelblatt, Jeanne S; Stout, Natasha; Trentham-Dietz, Amy (2011) To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 155:58-60
McElroy, T C; Kandl, K L; Garcia, J et al. (2003) Extinction-colonization dynamics structure genetic variation of spotted sunfish (Lepomis punctatus) in the Florida Everglades. Mol Ecol 12:355-68
van Keulen, H; Mertz, P M; LoVerde, P T et al. (1991) Characterization of a 54-nucleotide gap region in the 28S rRNA gene of Schistosoma mansoni. Mol Biochem Parasitol 45:205-14
Mertz, P M; Bobek, L A; Rekosh, D M et al. (1991) Schistosoma haematobium and S. japonicum: analysis of the ribosomal RNA genes and determination of the ""gap"" boundaries and sequences. Exp Parasitol 73:137-49
Smith, A J; Cho, M I; Hammarskjold, M L et al. (1990) Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J Virol 64:2743-50
Lu, X B; Heimer, J; Rekosh, D et al. (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci U S A 87:7598-602
Lewis, N; Williams, J; Rekosh, D et al. (1990) Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J Virol 64:1690-7
Hammarskjold, M L; Heimer, J; Hammarskjold, B et al. (1989) Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol 63:1959-66
Hammarskjold, M L; Rekosh, D (1989) The molecular biology of the human immunodeficiency virus. Biochim Biophys Acta 989:269-80

Showing the most recent 10 out of 18 publications